Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran
- PMID: 19862775
- DOI: 10.1002/dmrr.1038
Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran
Abstract
Background: The aim of this study was to estimate the progression rates from normal glucose tolerance (NGT) to impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and diabetes, and from IFG and IGT to diabetes in first-degree relatives (FDRs) of individuals with type 2 diabetes mellitus.
Methods: A total of 701 non-diabetic FDRs of consecutive patients with type 2 diabetes aged 20-70 years in 2003-2005 were followed through 2007 for the occurrence of IGT, IFG and type 2 diabetes. Glucose tolerance classification was based on the criteria of the American Diabetes Association and standard 75 g 2-h oral glucose tolerance test (OGTT).
Results: The progression rate from NGT to IFG, IGT and diabetes were 8.6% (95% confidence interval (CI) 6.8-10.6), 3.7% (95% CI: 2.5-5.1) and 0.5% (95% CI: 0.1-1.2) per year after an average of 27.6 months, respectively. Progression rates from IFG and IGT to diabetes were 5.1% (95% CI: 2.1-10.2) and 9.9% (95% CI: 7.7-12.6) per year.
Conclusions: To our knowledge, these are the first estimate of progression rates from NGT to IFG, IGT and diabetes in FDRs of individuals with type 2 diabetes in Iran. The progression rates to diabetes in these participants are high, and intensive follow-up and intervention strategies are recommended for these high-risk individuals.
Similar articles
-
Normalization of glucose intolerance in first-degree relatives of patients with type 2 diabetes.Diabetes Res Clin Pract. 2010 Jun;88(3):295-301. doi: 10.1016/j.diabres.2010.01.025. Epub 2010 Feb 18. Diabetes Res Clin Pract. 2010. PMID: 20167387
-
People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.Ann Nutr Metab. 2010;56(4):267-72. doi: 10.1159/000294752. Epub 2010 Apr 22. Ann Nutr Metab. 2010. PMID: 20413967
-
Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.Eur J Clin Invest. 2006 Nov;36(11):796-802. doi: 10.1111/j.1365-2362.2006.01728.x. Eur J Clin Invest. 2006. PMID: 17032347
-
Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.Diabetes Res Clin Pract. 2007 Dec;78(3):305-12. doi: 10.1016/j.diabres.2007.05.004. Epub 2007 Jun 29. Diabetes Res Clin Pract. 2007. PMID: 17601626 Review.
-
Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.Acta Med Indones. 2004 Jan-Mar;36(1):36-41. Acta Med Indones. 2004. PMID: 15673935 Review.
Cited by
-
Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study.Rev Diabet Stud. 2011 Winter;8(4):490-8. doi: 10.1900/RDS.2011.8.490. Epub 2012 Feb 10. Rev Diabet Stud. 2011. PMID: 22580730 Free PMC article.
-
Potential clinical biomarkers and perspectives in diabetic cardiomyopathy.Diabetol Metab Syndr. 2023 Mar 4;15(1):35. doi: 10.1186/s13098-023-00998-y. Diabetol Metab Syndr. 2023. PMID: 36871006 Free PMC article. Review.
-
Risk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program.BMC Public Health. 2013 Oct 26;13:1014. doi: 10.1186/1471-2458-13-1014. BMC Public Health. 2013. PMID: 24502249 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical